Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 59,337 | -8,011 | 7,763 | 22,570 | -54,789 |
| Depreciation Amortization | 1,623 | 1,210 | 795 | 415 | 1,021 |
| Accounts payable and accrued liabilities | -2,716 | -2,875 | -2,854 | -2,651 | 583 |
| Other Working Capital | -42,329 | -44,346 | -45,900 | -41,175 | -14,252 |
| Other Operating Activity | 14,082 | 11,710 | 8,148 | 5,265 | 7,297 |
| Operating Cash Flow | $29,997 | $-42,312 | $-32,048 | $-15,576 | $-60,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43 | -22 | -23 | -23 | -1,538 |
| Purchase Of Investment | -650 | -650 | -650 | -650 | -118,347 |
| Sale Of Investment | 59,000 | 56,000 | 39,650 | 25,500 | 136,850 |
| Investing Cash Flow | $58,307 | $55,328 | $38,977 | $24,827 | $16,965 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | N/A | 7,217 |
| Common Stock Issued | 30,082 | 29,695 | 29,441 | 413 | 279 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -81 |
| Financing Cash Flow | $40,082 | $39,695 | $39,441 | $413 | $7,415 |
| Beginning Cash Position | 48,350 | 48,350 | 48,350 | 48,350 | 84,110 |
| End Cash Position | 176,736 | 101,061 | 94,720 | 58,014 | 48,350 |
| Net Cash Flow | $128,386 | $52,711 | $46,370 | $9,664 | $-35,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,997 | -42,312 | -32,048 | -15,576 | -60,140 |
| Capital Expenditure | -43 | -22 | -23 | -23 | -1,538 |
| Free Cash Flow | 29,954 | -42,334 | -32,071 | -15,599 | -61,678 |